This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Nasdaq (NDAQ) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Nasdaq (NDAQ) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Nasdaq (NDAQ) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Nasdaq (NDAQ) delivered earnings and revenue surprises of 7.81% and 2.67%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
CME Group (CME) Q2 Earnings Top on Record Trading Volume
by Zacks Equity Research
CME Group (CME) Q2 results reflect benefits of record trading volumes.
Is a Beat in the Offing for Nasdaq (NDAQ) in Q2 Earnings?
by Zacks Equity Research
Nasdaq's (NDAQ) second-quarter performance is likely to have been driven by organic revenue growth and strong Market Platforms businesses, data and listing service revenues, and Adenza contributions.
Is a Beat in the Cards for CME Group (CME) in Q2 Earnings?
by Zacks Equity Research
CME Group's (CME) second-quarter 2024 results are likely to reflect a diverse product portfolio, increased volatility, as well as a strong market position.
Nasdaq (NDAQ) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Retain Nasdaq (NDAQ) in Your Portfolio
by Zacks Equity Research
Nasdaq (NDAQ) appears well poised on impressive organic growth, ramping up of on-trading revenue base, strategic buyouts to capitalize on market opportunities and effective capital deployment.
Nasdaq (NDAQ) and IDX Strengthen Technology Partnership
by Zacks Equity Research
Nasdaq's (NDAQ) partnership expansion with IDX is expected to promote efficiency in capital markets and increase transaction capacity.
Should You Retain Nasdaq (NDAQ) Stock in Your Portfolio?
by Zacks Equity Research
Nasdaq (NDAQ) is poised to grow on the back of its impressive organic growth, ramping up of on-trading revenue base and strategic buyouts to capitalize on growing market opportunities.
Nasdaq (NDAQ) & FIA Tech to Enhance Post Trade Infrastructure
by Zacks Equity Research
Nasdaq (NDAQ) and FIA Tech forge a partnership deal to reduce complexity and increase the reliability of post-trade infrastructure, leading to efficiency.
Cboe Global (CBOE) Q1 Earnings Top Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Cboe Global (CBOE) Q1 results reflect non-transaction revenue growth across market data fees, access and capacity fees, improved derivatives markets and data and access solutions net revenues.
Intercontinental (ICE) Q1 Earnings Meet Estimates, Revenues Lag
by Zacks Equity Research
Intercontinental (ICE) first-quarter results reflect the strength of a balanced and diversified business as well as the effects of the strategic investments it has made.
Nasdaq's (NDAQ) Q1 Earnings Miss, Revenues Top, Dividend Raised
by Zacks Equity Research
Nasdaq's (NDAQ) first-quarter results reflect lower Market Services net revenues and higher expenses. Listings, too, dropped in the reported quarter.
Nasdaq (NDAQ) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Nasdaq (NDAQ) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Nasdaq (NDAQ) Misses Q1 Earnings Estimates
by Zacks Equity Research
Nasdaq (NDAQ) delivered earnings and revenue surprises of -3.08% and 0.32%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
CME Group (CME) Q1 Earnings Top Estimates, Revenues Rise Y/Y
by Zacks Equity Research
CME Group (CME) Q1 results reflect higher revenues and increased average daily volume in four of its six asset classes.
Nasdaq (NDAQ) Set to Report Q1 Earnings: What to Expect
by Zacks Equity Research
Nasdaq's (NDAQ) first-quarter performance is likely to have been driven by organic revenue growth, and strong Market Platforms businesses, data and listing service revenues and Adenza contributions.
Wall Street's Insights Into Key Metrics Ahead of Nasdaq (NDAQ) Q1 Earnings
by Zacks Equity Research
Get a deeper insight into the potential performance of Nasdaq (NDAQ) for the quarter ended March 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Earnings Preview: Nasdaq (NDAQ) Q1 Earnings Expected to Decline
by Zacks Equity Research
Nasdaq (NDAQ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Stay Invested in Nasdaq (NDAQ) Stock
by Zacks Equity Research
Organic growth, ramping up of on-trading revenue base, strategic buyouts and effective capital deployment poise Nasdaq (NDAQ) for growth.
Will Nasdaq (NDAQ) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Nasdaq (NDAQ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks Industry Outlook Highlights Intercontinental Exchange, CME Group, Coinbase Global, Nasdaq and Cboe Global
by Zacks Equity Research
Intercontinental Exchange, CME Group, Coinbase Global, Nasdaq and Cboe Global have been highlighted in this Industry Outlook article.
5 Securities and Exchanges Stocks to Gain From Trading Volatility
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, COIN, NDAQ, and CBOE. However, compliance with regulations remains a challenge.
CME (CME) Up 4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
CME (CME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Hold Nasdaq (NDAQ) Stock Right Now
by Zacks Equity Research
Nasdaq (NDAQ) is poised to grow on the back of impressive organic growth, ramping up of on-trading revenue base and strategic buyouts to capitalize on growing market opportunities.